Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 27, Issue 7, 2003, Pages 464-470

  Kronstrand, Robert ^a   Seldén, Tor G ^a   Josefsson, Martin ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DRUG METABOLITE; GLUCURONIDE; METHADONE; NORBUPRENORPHINE; OPIATE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; DRUG ABUSE; DRUG DETERMINATION; HUMAN; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCREENING; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; URINALYSIS; URINARY EXCRETION;

BUPRENORPHINE; CHROMATOGRAPHY, LIQUID; GLUCURONIDES; HUMANS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION;

EID: 0141459508     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/27.7.464     Document Type: Article

References (20)

1. E.J. Cone, C.W. Gorodetzky, D. Yousefnejad, W.F. Buchwald, and R.E. Johnson. The metabolism and excretion of buprenorphine in humans. Drug Metab. Dispos. 12: 577-581 (1984).
2. L. Debrabandere, M. Van Boven, and P. Daenens. Analysis of buprenorphine in urine specimens. J. Forensic Sci. 37: 82-89 (1991).
3. S. Feng, M.A. ElSohly, and D.T. Duckworth. Hydrolysis of conjugated metabolites of buprenorphine. I. The quantitative enzymatic hydrolysis of buprenorphine-3-β-D-glucuronide in human urine. J. Anal. Toxicol. 25: 589-593 (2001).
4. A.M. Lisi, R. Kazlauskas, and G.J. Trout. Gas chromatographic-mass spectrometric quantitation of urinary buprenorphine and norbuprenorphine after derivatization by direct extractive alkylation. J. Chromatogr. B 692: 67-77 (1997).
5. F. Vincent, J. Bessard, J. Vacheron, M. Mallaret, and G. Bessard. Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry. J. Anal. Toxicol. 23: 270-279 (1999).
6. A. Tracqui, P. Kintz, and B. Ludes. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol. 22: 430-434 (1998).
7. C.W. Hand, K.E. Ryan, S.K. Dutt, R.A. Moore, J. O'Connor, D. Talbot, and H.J. McQuay. Radioimmunoassay of buprenorphine in urine: studies in patients and in a drug clinic. J. Anal. Toxicol. 13: 100-104 (1989).
8. C.W. Hand, D. Baldwin, R.A. Moore, M.C. Allen, and H.J. McQuay. Radioimmunoassay of buprenorphine with iodine label: analysis of buprenorphine and metabolites in human plasma. Ann. Clin. Biochem. 23:47-53 (1986).
9. E.J. Cone, C.W. Gorodetzky, D. Yousefnejad, and W.D. Darwin. 63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces. J. Chromatogr. 337: 291-300 (1985).
10. E.T. Everhart, P. Cheung, P. Shwonek, K. Zabel, E.C. Tisdale, P. Jacob, J. Mendelson, and R.T. Jones. Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine. Clin. Chem. 43: 2292-2302 (1997).
11. E. Schleyer, R. Lohmann, C. Rolf, A. Gralow, C.C. Kaufmann, M. Unterhalt, and W. Hiddemann. Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection. J. Chromatogr. 614: 275-283 (1993).
12. Y. Blom, U. Bondesson, and E. Anggard. Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. J. Chromatogr. 338: 89-98 (1985).
13. A. Tracqui, P. Kintz, and P. Mangin. HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J. Forensic Sci. 42: 111-114 (1997).
14. J.J. Kuhlman Jr., J. Magluilo Jr., E.J. Cone, and B. Levine. Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization-tandem mass spectrometry. J. Anal. Toxicol. 20: 229-235 (1996).
15. D.E. Moody, M.H. Slawson, E.C. Strain, J.D. Laycock, A.C. Spanbauer, and R.L. Foltz. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies. Anal. Biochem. 306: 31-39 (2002).
16. M. Ohtani, F. Shibuya, H. Kotaki, K. Uchino, Y. Saitoh, and F. Nakagawa. Quantitative determination of buprenorphine and its active metabolite, norbuprenorphine, in human plasma by gas chromatography-chemical ionization mass spectrometry. J. Chromatogr. 487: 469-475 (1989).
17. A. Polettini and M.A. Huestis. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-3-glucuronide in plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 754: 447-459 (2001).
18. P. Kintz A new series of 13 buprenorphine-related deaths. Clin. Biochem. 35: 513-516 (2002).
19. Z. Lin, P. Lafolie, and O. Beck. Evaluation of analytical procedures for urinary codeine and morphine measurements. J. Anal. Toxicol. 18: 129-133 (1994).
20. M. Josefsson, R. Kronstrand, J. Andersson, and M. Roman. Evaluation of electrospray ionisation liquid chromatography-tandem mass spectrometry for rational determination of a number of neuroleptics and their major metabolites in human body fluids and tissue. J. Chromatogr. B 789: 151-167 (2003).